The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.68
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.12 (0.281%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 42.68
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of 100th development

29 Jun 2023 07:00

RNS Number : 3005E
Assura PLC
29 June 2023
 

29 June 2023

Assura plc

 

Completion of 100th development

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces the practical completion of its 100th development - Prestbury Medical Centre in Wolverhampton - as it marks two decades of developing healthcare infrastructure in the UK.

 

Jonathan Murphy, CEO, said:

"We are proud to have supported the delivery of health care for two decades, creating high-quality premises that serve the needs of health professionals and patients in a primary care setting and generating value for shareholders.

"The new Prestbury Medical Centre in Wolverhampton will provide an essential new home for two relocating GP practices, serving a growing patient list of over 14,500 people and allow additional health services to be moved out of hospital into a community setting. We are pleased to have again worked with Medcentres to deliver this much-needed community facility and that our funding approach has allowed further sustainability enhancements to be made for the benefit of the GPs, health professionals and patients that will use the building.

"As the leading developer in our sector, we have now completed 100 buildings over the course of our 20-year history - delivering modern, fit-for-purpose facilities which are vital for the long-term delivery of community health services that ease the pressures currently being faced by the NHS."

Prestbury Medical Centre, Wolverhampton

 

The £6 million forward-funded scheme accommodates the health needs of a growing local population, providing state-of-the-art, modern premises for over 14,500 patients. It sees two local surgeries relocating from previous premises that were not fit for purpose and, alongside facilitating critical GP services, will allow the provision of additional training capacity, a greater range of community and out-of-hospital services as well as incorporating a telehealth hub to support digital health care delivery.

 

In line with Assura's sustainability strategy, the building has been designed to achieve BREEAM "Excellent" certification ("Outstanding" for energy efficiency) and an EPC rating of "A". These ratings have been achieved through delivering an energy solution incorporating air source heat pumps, EV charging points and use of natural ventilation, as well as 70 m2 of photo-voltaic ("PV") panels.

 

Interiors also reflect the "Designing for Everyone" toolkit launched by Assura in 2022, which seeks to support GP practices in improving their build environments for people with disabilities and conditions such as dementia, neurodiversity and anxiety.

 

The building, developed under a forward-funding agreement with Medcentres PLC, is 100% let to the GPs on a 25-year lease with open market rent reviews every three years and is a priority project for the NHS Black Country Integrated Care Board.

 

- ENDS -

 

 

 

 

 

Assura plc David Purcell, Investor Relations Director

Tel: 01925 945354 Email: Investor@assura.co.uk

 

FGS Global

Gordon SimpsonJames Thompson

 

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

 

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUWSWROWUNUAR
Date   Source Headline
5th Nov 20209:52 amRNSNotice of Interim Results
4th Nov 20207:00 amRNSIssue of Consideration Shares
22nd Oct 20204:48 pmRNSHolding(s) in Company
19th Oct 202012:13 pmRNSDirector/PDMR Shareholding
12th Oct 20204:54 pmRNSScrip Dividend Declaration
7th Oct 202012:11 pmRNSDirector/PDMR Shareholding
7th Oct 202012:05 pmRNSCorrection to Trading Update
7th Oct 20207:00 amRNSTrading Update
25th Sep 20201:50 pmRNSHolding(s) in Company
23rd Sep 202012:07 pmRNSDirector/PDMR Shareholding
17th Sep 202010:30 amRNSScrip Calculation Price
16th Sep 20207:00 amRNSVirtual Property Tour
8th Sep 20204:19 pmRNSPricing of £300m Social Bond
4th Sep 20202:36 pmRNSDirector/PDMR Shareholding
4th Sep 20202:34 pmRNSAdditional Listing
3rd Sep 20201:31 pmRNSNotice of Dividend
20th Aug 20203:02 pmRNSNotification of Major Interests in Shares
3rd Aug 202011:11 amRNSDirector/PDMR Shareholding
24th Jul 20203:04 pmRNSExercise of Nil Cost Options under PSP
21st Jul 20207:00 amRNSAdditional Listing
16th Jul 20207:00 amRNSDirector/PDMR Shareholding
14th Jul 202012:54 pmRNSPDMR Notification
9th Jul 20207:00 amRNSScrip Dividend Declaration
8th Jul 20201:42 pmRNSNotification of Major Interests in Shares
7th Jul 20203:12 pmRNSResult of AGM
7th Jul 20207:00 amRNSTrading update
1st Jul 20201:25 pmRNSNotification of Major Interests in Shares
24th Jun 20208:00 amRNSNotification of Major Interests in Shares
18th Jun 20202:43 pmRNSScrip Calculation Price
15th Jun 20205:15 pmRNSNotification of Major Interests in Shares
12th Jun 20203:54 pmRNSDirector/PDMR Shareholding
12th Jun 202011:47 amRNSAmended Notice of AGM
9th Jun 20202:04 pmRNSAnnual Report and Notice of AGM
4th Jun 202010:01 amRNSNotice of dividend
21st May 20207:00 amRNSAssura Full Year Results
11th May 20207:00 amRNSConfirmation of announcement date for results
16th Apr 202010:50 amRNSDirector/PDMR Shareholding
14th Apr 202012:38 pmRNSReplacement Scrip Dividend Declaration
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
9th Apr 20207:00 amRNSScrip Dividend Declaration
7th Apr 20207:00 amRNSResults of Placing
6th Apr 20204:42 pmRNSProposed equity placing of new ordinary shares
2nd Apr 20207:00 amRNSTrading update
20th Mar 20207:00 amRNSScrip Calculation Price
13th Mar 20204:46 pmRNSNotification of Major Interests in Shares
5th Mar 20207:00 amRNSNotice of Dividend
24th Feb 20203:40 pmRNSNotification of Major Interests in Shares
20th Feb 20209:13 amRNSNotification of Major Interests in Shares
17th Jan 202011:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.